Sun Pharma Advanced Research Company Limited (SPARC) — Cash Flow Quality Index

Latest as of December 2022: 0.62x

Sun Pharma Advanced Research Company Limited (SPARC) has a Cash Flow Quality Index of 0.62x as of December 2022. Operating cash flow of Rs62.60 Million is below net income of Rs101.50 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Sun Pharma Advanced Research Company Lim (SPARC) cash conversion ratio to assess how effectively this company generates cash.

Cash Flow Quality Index

0.62x
Operating CF / Net Income

Operating Cash Flow

Rs62.60 Million
INR

Net Income

Rs101.50 Million
INR

Data as of

Dec 2022
Most recent filing

Sun Pharma Advanced Research Company Limited Cash Flow Quality Index (2014–2014)

Historical Cash Flow Quality Index for Sun Pharma Advanced Research Company Limited across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check SPARC total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Sun Pharma Advanced Research Company Limited (2014–2014)

Year-by-year earnings quality comparison for Sun Pharma Advanced Research Company Limited. For live market cap and the full company financial profile, see Sun Pharma Advanced Research Company Lim market capitalisation.

Year Quality Index Operating CF (INR) Net Income YoY Change
2014 1.07x Rs368.95 Million Rs343.24 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.